Comment on "Intravitreal conbercept injection for neovascular age-related macular degeneration" Reply

被引：0
|
作者：
Wu, Bing-Hui [1 ]
Wang, Bing [1 ]
Wu, Hui-Qin [1 ]
Chang, Qin [1 ]
Lu, Hui-Qin [1 ]
机构：
[1] Xian 1 Hosp, Dept Ophthalmol, Xian 710001, Shaanxi, Peoples R China
来源：
INTERNATIONAL JOURNAL OF OPHTHALMOLOGY | 2020年 / 13卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：363 / 364
页数：2
相关论文
共 50 条
  • [31] Bilateral occlusive vasculitis after intravitreal injection of brolucizumab in neovascular age-related macular degeneration
    Riedel, Anna Maria
    Lackerbauer, Carlo
    Lohmann, Chris P.
    Ulbig, Michael
    OPHTHALMOLOGIE, 2022, 119 (01): : 75 - 78
  • [32] Early fluid clearance following intravitreal ranibizumab injection for neovascular age-related macular degeneration
    Jao, Kathy
    Chauhan, Devinder
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [33] Comparison between Aflibercept, Ranibizumab Intravitreal Injection on Neovascular Age-related Macular Degeneration Patients
    Min, Ji Sang
    Jung, Hyun Chul
    Suh, Ji Young
    Kwon, Yoon Hyung
    JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2016, 57 (11): : 1738 - 1744
  • [34] Retinal Blood Flow in Response to an Intravitreal Injection of Ranibizumab for Neovascular Age-Related Macular Degeneration
    Micieli, J. A.
    Wong, T.
    Lam, W. -C.
    Brent, M. H.
    Devenyi, R. G.
    Hudson, C.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [35] Intravitreal Bevacizumab Injection in Patients With Neovascular Age-Related Macular Degeneration and Low Visual Acuity
    El Matri, L.
    Bouraoui, R.
    Landolsi, H.
    Kort, F.
    Chebil, A.
    Limaiem, R.
    Mghaieth, F.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [36] Intravitreal bevacizumab (avastin) for subfoveal neovascular age-related macular degeneration
    Levy J.
    Shneck M.
    Rosen S.
    Klemperer I.
    Rand D.
    Weinstein O.
    Pitchkhadze A.
    Belfair N.
    Lifshitz T.
    International Ophthalmology, 2009, 29 (5) : 349 - 357
  • [37] Intravitreal bevacizumab (avastin) treatment of neovascular age-related macular degeneration
    Emerson, M. Vaughn
    Lauer, Andreas K.
    Flaxel, Christina J.
    Wilson, David J.
    Francis, Peter J.
    Stout, J. Timothy
    Emerson, Geoffrey G.
    Schlesinger, Thomas K.
    Nolte, Susan K.
    Klein, Michael L.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2007, 27 (04): : 439 - 444
  • [38] Increasing concentrations of intravitreal therapies for neovascular age-related macular degeneration
    Chew, Emily Y.
    LANCET, 2024, 403 (10432): : 1110 - 1111
  • [39] Systemic and intravitreal Bevacizumab (Avastin®) in neovascular age-related macular degeneration
    Michels, S.
    Prager, F.
    Geitzenauer, W.
    Lackner, B.
    Sacu, S.
    Weigert, G.
    Kriechbaum, K.
    Polak, K.
    Georgopoulos, M.
    Schmidt-Erfurth, U.
    SPEKTRUM DER AUGENHEILKUNDE, 2007, 21 (03) : 154 - 159
  • [40] Intravitreal Faricimab for Previously Treated Neovascular Age-Related Macular Degeneration
    Hang, Abraham
    Ngo, Taylor
    Virk, Jaipreet Singh
    Moussa, Kareem
    Moshiri, Ala
    Emami-Naeini, Parisa
    Park, Susanna S.
    CLINICAL OPHTHALMOLOGY, 2024, 18 : 3781 - 3789
12345